These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30830447)

  • 1. Breath metabolome of mice infected with Pseudomonas aeruginosa.
    Purcaro G; Nasir M; Franchina FA; Rees CA; Aliyeva M; Daphtary N; Wargo MJ; Lundblad LKA; Hill JE
    Metabolomics; 2019 Jan; 15(1):10. PubMed ID: 30830447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in the concentrations of volatile metabolites emitted by genotypically different strains of Pseudomonas aeruginosa.
    Shestivska V; Spaněl P; Dryahina K; Sovová K; Smith D; Musílek M; Nemec A
    J Appl Microbiol; 2012 Sep; 113(3):701-13. PubMed ID: 22726261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volatile fingerprinting of Pseudomonas aeruginosa and respiratory syncytial virus infection in an in vitro cystic fibrosis co-infection model.
    Purcaro G; Rees CA; Melvin JA; Bomberger JM; Hill JE
    J Breath Res; 2018 Jul; 12(4):046001. PubMed ID: 29735804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa Volatilome Characteristics and Adaptations in Chronic Cystic Fibrosis Lung Infections.
    Davis TJ; Karanjia AV; Bhebhe CN; West SB; Richardson M; Bean HD
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33028687
    [No Abstract]   [Full Text] [Related]  

  • 5. Do linear logistic model analyses of volatile biomarkers in exhaled breath of cystic fibrosis patients reliably indicate Pseudomonas aeruginosa infection?
    Španěl P; Sovová K; Dryahina K; Doušová T; Dřevínek P; Smith D
    J Breath Res; 2016 Aug; 10(3):036013. PubMed ID: 27532768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of volatile metabolites from in vitro biofilms of Pseudomonas aeruginosa with thin-film microextraction by thermal desorption gas chromatography-mass spectrometry.
    Koehler T; Ackermann I; Brecht D; Uteschil F; Wingender J; Telgheder U; Schmitz OJ
    Anal Bioanal Chem; 2020 May; 412(12):2881-2892. PubMed ID: 32198528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of the volatile metabolomes of Pseudomonas aeruginosa clinical isolates.
    Bean HD; Rees CA; Hill JE
    J Breath Res; 2016 Nov; 10(4):047102. PubMed ID: 27869104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro volatile organic compound profiling using GC×GC-TOFMS to differentiate bacteria associated with lung infections: a proof-of-concept study.
    Nizio KD; Perrault KA; Troobnikoff AN; Ueland M; Shoma S; Iredell JR; Middleton PG; Forbes SL
    J Breath Res; 2016 Apr; 10(2):026008. PubMed ID: 27120170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of an extended human volatome with comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry.
    Phillips M; Cataneo RN; Chaturvedi A; Kaplan PD; Libardoni M; Mundada M; Patel U; Zhang X
    PLoS One; 2013; 8(9):e75274. PubMed ID: 24086492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics of volatile organic compounds in cystic fibrosis patients and controls.
    Robroeks CM; van Berkel JJ; Dallinga JW; Jöbsis Q; Zimmermann LJ; Hendriks HJ; Wouters MF; van der Grinten CP; van de Kant KD; van Schooten FJ; Dompeling E
    Pediatr Res; 2010 Jul; 68(1):75-80. PubMed ID: 20351658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa.
    Filipiak W; Sponring A; Baur MM; Filipiak A; Ager C; Wiesenhofer H; Nagl M; Troppmair J; Amann A
    BMC Microbiol; 2012 Jun; 12():113. PubMed ID: 22716902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal chemometric approach for the analysis of human exhaled breath in lung cancer patients by TD-GC × GC-TOFMS.
    Pesesse R; Stefanuto PH; Schleich F; Louis R; Focant JF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 May; 1114-1115():146-153. PubMed ID: 30745111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breathomics to diagnose systemic sclerosis using thermal desorption and comprehensive two-dimensional gas chromatography high-resolution time-of-flight mass spectrometry.
    Zanella D; Guiot J; Stefanuto PH; Giltay L; Henket M; Guissard F; André B; Malaise M; Potjewijd J; Schleich F; Louis R; Focant JF
    Anal Bioanal Chem; 2021 Jun; 413(14):3813-3822. PubMed ID: 33903944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive two-dimensional gas chromatographic platforms comparison for exhaled breath metabolites analysis.
    Zanella D; Henin A; Mascrez S; Stefanuto PH; Franchina FA; Focant JF; Purcaro G
    J Sep Sci; 2022 Sep; 45(18):3542-3555. PubMed ID: 35853166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of real-time and hyphenated mass spectrometry for improved characterisation of exhaled breath biomarkers in clinical research.
    Lamy E; Roquencourt C; Zhou B; Salvator H; Moine P; Annane D; Devillier P; Bardin E; Grassin-Delyle S
    Anal Bioanal Chem; 2024 Sep; 416(22):4929-4939. PubMed ID: 38980330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary investigation of human exhaled breath for tuberculosis diagnosis by multidimensional gas chromatography - Time of flight mass spectrometry and machine learning.
    Beccaria M; Mellors TR; Petion JS; Rees CA; Nasir M; Systrom HK; Sairistil JW; Jean-Juste MA; Rivera V; Lavoile K; Severe P; Pape JW; Wright PF; Hill JE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Feb; 1074-1075():46-50. PubMed ID: 29331743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial volatile discovery using solid phase microextraction and comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry.
    Bean HD; Dimandja JM; Hill JE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 901():41-6. PubMed ID: 22727751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel coupling technique based on thermal desorption gas chromatography with mass spectrometry and ion mobility spectrometry for breath analysis.
    Schanzmann H; Ruzsanyi V; Ahmad-Nejad P; Telgheder U; Sielemann S
    J Breath Res; 2023 Dec; 18(1):. PubMed ID: 38100823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of volatile metabolites released in vitro by bacteria of the genus Stenotrophomonas for identification of breath biomarkers of respiratory infection in cystic fibrosis.
    Shestivska V; Dryahina K; Nunvář J; Sovová K; Elhottová D; Nemec A; Smith D; Španěl P
    J Breath Res; 2015 Apr; 9(2):027104. PubMed ID: 25830686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
    Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
    Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.